Friday, December 13, 2024
No menu items!

Hydroxychloroquine COVID-19

Hydroxychloroquine Trials for COVID-19 Suspended by WHO

The World Health Organization (WHO) announced that it is pausing clinical trials on the use of the controversial malaria drug, hydroxychloroquine, to treat patients with COVID-19. This was one of four experimental treatments being investigated by the organization and...
- Advertisement -spot_img

Latest News

Workday Unveils New Ai Capabilities to Enhance Employee Insights

Workday Rising EMEA – Workday, Inc. (NASDAQ: WDAY), a leading provider of solutions to help organisations manage their people...
- Advertisement -spot_img